Parallax Volatility Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-49,279
| Closed | -$396K | – | 539 |
|
|
2025
Q1 | $396K | Buy |
49,279
+9,647
| +24% | +$77.6K | ﹤0.01% | 364 |
|
|
2024
Q4 | $356K | Sell |
39,632
-33,540
| -46% | -$301K | ﹤0.01% | 436 |
|
|
2024
Q3 | $536K | Sell |
73,172
-6,718
| -8% | -$49.2K | ﹤0.01% | 401 |
|
|
2024
Q2 | $456K | Sell |
79,890
-7,825
| -9% | -$44.7K | ﹤0.01% | 401 |
|
|
2024
Q1 | $439K | Sell |
87,715
-47,674
| -35% | -$239K | ﹤0.01% | 386 |
|
|
2023
Q4 | $1.22M | Sell |
135,389
-28,858
| -18% | -$259K | ﹤0.01% | 297 |
|
|
2023
Q3 | $1.28M | Buy |
164,247
+13,295
| +9% | +$103K | ﹤0.01% | 270 |
|
|
2023
Q2 | $1.46M | Buy |
150,952
+8,503
| +6% | +$82.3K | ﹤0.01% | 258 |
|
|
2023
Q1 | $1.56M | Sell |
142,449
-107,730
| -43% | -$1.18M | ﹤0.01% | 244 |
|
|
2022
Q4 | $1.08M | Buy |
250,179
+3,616
| +1% | +$15.6K | ﹤0.01% | 327 |
|
|
2022
Q3 | $1.85M | Buy |
246,563
+46,082
| +23% | +$347K | ﹤0.01% | 294 |
|
|
2022
Q2 | $2.02M | Sell |
200,481
-1,927
| -1% | -$19.4K | ﹤0.01% | 284 |
|
|
2022
Q1 | $2.51M | Buy |
+202,408
| New | +$2.51M | ﹤0.01% | 265 |
|
|
2017
Q4 | – | Sell |
-49,702
| Closed | -$312K | – | 2751 |
|
|
2017
Q3 | $312K | Buy |
49,702
+30,951
| +165% | +$194K | ﹤0.01% | 324 |
|
|
2017
Q2 | $115K | Sell |
18,751
-31,294
| -63% | -$192K | ﹤0.01% | 398 |
|
|
2017
Q1 | $367K | Sell |
50,045
-7,426
| -13% | -$54.5K | ﹤0.01% | 327 |
|
|
2016
Q4 | $121K | Buy |
+57,471
| New | +$121K | ﹤0.01% | 465 |
|